FDA Restricts The Use Of 2 Monoclonal Antibody Treatments!

The FDA is about to restrict the use of two monoclonal antibody treatments, stated the Washington Post!

They added that the Biden Administration would halt the distribution of monoclonal antibody treatments made by Regeneron Pharmaceuticals and Eli Lilly due to its ineffectiveness against Omicron.

Join The True Defender Telegram Chanel Here:

The Washington Post shared:

The Food and Drug Administration is poised as soon as Monday to restrict two monoclonal antibodies, saying the covid-19 treatments should not be employed in any states because they are ineffective against the dominant omicron variant, according to two senior administration health officials.

As a result, the Biden administration will pause distribution of the therapies, manufactured by Regeneron Pharmaceuticals and Eli Lilly, to the states.

“We want to make sure that patients get treatments that are effective, not treatments that don’t work,” said one of the officials, who spoke on the condition of anonymity to describe internal discussions.

The FDA action will involve revising the emergency use authorizations for the monoclonal antibodies. The agency will not revoke the authorizations in case the treatments become useful against a future coronavirus variant.

The Centers for Disease Control and Prevention has estimated that more than 99 percent of current covid-19 cases are caused by omicron.

Biden administration officials noted that several therapies remain effective against omicron, including sotrovimab — a monoclonal antibody made by GlaxoSmithKline and Vir Biotechnology — and antiviral pills by Pfizer and by Merck and its partner, Ridgeback Biotherapeutics.

In addition, the use of the antiviral drug remdesivir as an outpatient therapy recently got the green light from regulators. However, some of the treatments, including the Pfizer pill and sotrovimab, are experiencing supply shortages.

Dems death panels?

At the beginning of this month, the PV shared the never before seen military documents about the C-19 origin, gain-of-function research, shots, potential treatments, and the government’s effort to conceal everything.

The docs include evidence that Ivermectin and hydroxychloroquine were highly effective in treating the virus because they inhibited the viral replication that spread the spike protein around the body.

There have been 67 Ivermectin studies showing a 67% improvement in C-19 patients. And 298 Hydroxychloroquine studies showed 64% improvement in C-19 patients.

These two drugs are life-saving monoclonal antibody treatments that will be restricted, but the vaccines and the anti-viral pills are still being distributed.

The Washington Post The Gateway Pundit C-19

Addison Wilson

A passionate teacher in English Language and Literature ready to give her best! Developing and implementing diverse curriculums covering a wide range of subjects. With my problem-solving skills, every job will be easily completed, so punctuation is my strength. Highly skilled at motivating students through positive encouragement and reinforcement of concepts via interactive classroom instruction and observation. My working style fits every personality type, so it makes me a great team player. I have completed numerous journalistic projects successfully, so digging for further information is my field. Fighter for freedom of speech! The truth must be revealed!

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Back to top button

Adblock Detected

For continue reading on the site please disable the Ad-block